chr6-165301975-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_144980.4(C6orf118):c.347C>T(p.Thr116Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00131 in 1,613,586 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_144980.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000644 AC: 98AN: 152140Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000522 AC: 131AN: 250862Hom.: 0 AF XY: 0.000457 AC XY: 62AN XY: 135618
GnomAD4 exome AF: 0.00138 AC: 2011AN: 1461446Hom.: 2 Cov.: 35 AF XY: 0.00126 AC XY: 918AN XY: 727014
GnomAD4 genome AF: 0.000644 AC: 98AN: 152140Hom.: 0 Cov.: 31 AF XY: 0.000552 AC XY: 41AN XY: 74304
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 16, 2021 | The c.347C>T (p.T116M) alteration is located in exon 2 (coding exon 2) of the C6orf118 gene. This alteration results from a C to T substitution at nucleotide position 347, causing the threonine (T) at amino acid position 116 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at